ENVALITH
堺化学工業株式会社 logo

SAKAI CHEMICAL INDUSTRY CO., LTD.

4078・Prime Market・Chemicals

堺化学工業株式会社 logo
SAKAI CHEMICAL INDUSTRY CO., LTD.4078

Electronic Materials

Core growth business of Sakai Chemical achieving increased revenue and profit driven by strong demand for AI servers and automotive applications.

PeriodCurrentPreviousChange
Net Sales (External Customers)¥11,377 million (full year FY2026, ending March 2026)¥10,014 million (full year FY2025, ended March 2025)↑
Operating Profit¥1,816 million (full year FY2026, ending March 2026)¥1,493 million (full year FY2025, ended March 2025)↑
Segment Assets¥15,788 million (end of FY2026, ending March 2026)¥13,716 million (end of FY2025, ended March 2025)↑
Depreciation and Amortization¥860 million (full year FY2026, ending March 2026)¥776 million (full year FY2025, ended March 2025)↑
Increase in Tangible and Intangible Assets¥971 million (full year FY2026, ending March 2026)¥1,837 million (full year FY2025, ended March 2025)↓
YoY Change in Net Sales+13.6% (FY2026, ending March 2026)—↑
YoY Change in Operating Profit+21.7% (FY2026, ending March 2026)—↑

Business Details

A growth business segment that manufactures and sells High-Purity Dielectric Powder, Dielectric (for MLCC), and related products. Dielectric materials and dielectric products for multilayer ceramic capacitors (MLCC) are the mainstay products, supplied domestically and internationally for automotive, AI server, and consumer electronics applications. Under the medium-term management plan 'Transformation, BEYOND2030,' this segment is positioned as a strategic core business aiming to grow beyond market growth by expanding share in high-end and mid-end products.

Recent Overview

Achieved a 13.6% increase in revenue and a 21.7% increase in operating profit, driven by strong AI server and automotive demand.

In FY2026 (ending March 2026), Dielectric (for MLCC) saw increases in both revenue and profit due to strong performance in AI server-related and automotive applications. Dielectric Materials also performed favorably overall, despite a temporary shipment adjustment from one customer, resulting in increased revenue and profit for both product lines. Net sales were ¥11,377 million (up 13.6% year-on-year), and operating profit was ¥1,816 million (up 21.7% year-on-year), with segment assets also expanding to ¥15,788 million.

Key Products

product
High-Purity Dielectric Powder (Dielectric Materials)

High-purity dielectric powder that serves as the raw material for multilayer ceramic capacitors (MLCC). Demand is expanding, centered on AI server-related and automotive applications. In FY2026 (ending March 2026), although there was a temporary shipment adjustment from one customer, overall performance was favorable, and both revenue and profit increased.

product
Dielectric (for MLCC)

Dielectric products used in automotive electronic components and MLCC for AI servers. In FY2026 (ending March 2026), AI server-related and automotive demand were strong, resulting in increases in both revenue and profit.

product
High-Brightness Inorganic Luminescent Materials

High-brightness inorganic luminescent materials for various display and lighting applications. One of the product lineups within the Electronic Materials segment.

Growth Drivers

  • Continued expansion of demand for AI server-related dielectric and dielectric materials
  • Strong trend in automotive MLCC demand
  • Strategy to expand share in high-end and mid-end products under the medium-term management plan
  • Improved profitability through the penetration of price revisions (both dielectric and dielectric materials)
  • Overseas expansion through the global sales network (Sakai Trading Co., Ltd., SAKAI TRADING NEW YORK INC., etc.)

Risks

  • Risk of demand fluctuation due to temporary shipment adjustments by customers
  • Risk of spillover to the MLCC market due to uncertainty and slowdown in the Chinese economy
  • Risk of renewed slowdown in the automotive-related market (recurrence of sluggish shipment movement)
  • Impact on the supply chain and demand from trade policy changes such as reciprocal tariffs
  • Increasing difficulty in maintaining high-end product share due to intensifying price competition with competitors
  • Risk of rising manufacturing costs due to higher raw material and fuel prices and yen depreciation

Cosmetic Materials

Growth business segment providing inorganic materials for UV care and makeup applications

PeriodCurrentPreviousChange
Net Sales¥1,720 million¥2,676 million↓
Operating Profit (Loss)-¥437 million¥293 million↓
Segment Assets¥4,107 million¥5,722 million↓
Depreciation and Amortization¥171 million¥210 million↓
Increase in Tangible and Intangible Assets¥1,781 million¥774 million↑
Impairment Loss¥2,962 million¥0 million↓

Business Details

A segment that manufactures and sells Ultrafine Zinc Oxide, Ultrafine Titanium Oxide, Plate-Shaped Barium Sulfate, and related products. The main application is UV care cosmetics, centered on sunscreen products, supplied to domestic and overseas cosmetics manufacturers. Positioned as a growth business under the medium-term management plan 'Transformation, BEYOND2030,' but in FY2026 (ending March 2026), shipment volumes to major customers and to China declined significantly, and combined with rising manufacturing costs due to lower capacity utilization, process suspension costs, and inventory valuation losses, the segment fell into a substantial decrease in revenue and an operating loss.

Recent Overview

Fell into a 35.7% decrease in revenue and an operating loss of ¥437 million due to a significant decline in shipment volumes and lower capacity utilization

In FY2026 (ending March 2026), shipment volumes of Ultrafine Zinc Oxide and Ultrafine Titanium Oxide for UV care cosmetic materials declined significantly, centered on major customers and China, resulting in net sales of ¥1,720 million, down 35.7% year-on-year. In addition to rising manufacturing costs due to lower capacity utilization, an operating loss of ¥437 million was recorded due to process suspension costs and inventory valuation losses, among other factors. Furthermore, an impairment loss of ¥2,962 million was recorded in the segment (related to assets for the construction of a cosmetic materials plant, etc.). On the other hand, the increase in tangible and intangible assets was ¥1,781 million, an increase from the prior period, indicating that upfront investment in the construction of a new plant is continuing.

Key Products

product
Ultrafine Zinc Oxide

Ultrafine zinc oxide used in UV care cosmetics, centered on sunscreens. Achieves both high transparency and UV-blocking performance, supplied to domestic and overseas cosmetics manufacturers. China is one of the major sales destinations, but shipment volumes declined significantly in FY2026 (ending March 2026).

product
Ultrafine Titanium Oxide

A mainstay material for UV care cosmetics alongside zinc oxide. In FY2026 (ending March 2026), shipment volumes declined significantly, similar to zinc oxide, resulting in decreases in both revenue and profit.

product
Plate-Shaped Barium Sulfate

Plate-shaped barium sulfate used in makeup and skincare cosmetics. A product responsible for expansion into the cosmetics market beyond UV care applications.

Growth Drivers

  • Establishment of a supply system and development of new applications through increased production capacity following the completion of new plant construction
  • Promotion of expanded sales to overseas cosmetics manufacturers, primarily in Europe
  • Diversification of applications through the development of new products for the makeup and skincare market
  • Differentiated appeal of high-transparency zinc oxide leveraging formulation proposal capabilities
  • Recovery of shipment volumes as demand recovers in the Chinese market

Risks

  • Risk of continued sluggish shipment volumes due to the economic slowdown in China and inventory adjustments by major customers
  • Risk of recurrence of rising manufacturing costs, process suspension costs, and inventory valuation losses due to lower capacity utilization
  • Increased burden of upfront investment and startup risk associated with the construction of a new plant
  • Risk of declining profitability of fixed assets, as seen in the large-scale impairment loss (¥2,962 million) recorded in FY2026 (ending March 2026)
  • High dependence on the Chinese market in the sunscreen market and associated geopolitical risk
  • Intensifying competition and price competition risk in the UV care cosmetics market

Organic Chemicals

A growth business segment centered on Organic Sulfur Compounds and pharmaceutical CDMO

PeriodCurrentPreviousChange
Net Sales (External Customers)¥7,185 million¥6,638 million↑
Operating Profit¥721 million¥770 million↓
Segment Assets¥14,653 million¥14,900 million↓
Depreciation and Amortization¥733 million¥550 million↑
Capital Expenditures (Increase in Tangible and Intangible Assets)¥1,152 million¥3,118 million↓

Business Details

A growth business segment centered on Organic Sulfur Compounds (Thio Products) and contract manufacturing (CDMO) of pharmaceutical APIs and intermediates. The Company and Katayama Seiyakusho Co., Ltd. handle manufacturing and sales, while Sakai Trading Co., Ltd. and Sakai Trading Taiwan Co., Ltd. support sales. Major customers include plastic lens manufacturers, cement additive manufacturers in China and Europe, and pharmaceutical companies. Positioned as a growth driver alongside Electronic Materials and Cosmetic Materials under the medium-term management plan 'Transformation, BEYOND2030,' with active investment underway to expand the CDMO framework.

Recent Overview

Revenue increased but profit decreased; strong Thio Products offset by increased CDMO fixed costs pressuring profit

In FY2026 (ending March 2026), net sales reached ¥7,185 million (up 8.2% year-on-year), achieving revenue growth. Organic Sulfur Compounds saw both revenue and profit increase due to successful increases in sales volume and price corrections for lens applications and for cement additives in China and Europe. Meanwhile, in CDMO, net sales grew due to an increase in volume of existing contracted products, but overall segment operating profit decreased to ¥721 million (down 6.4% year-on-year) due to the increased burden of depreciation expenses from Katayama Seiyakusho Co., Ltd.'s new headquarters and research laboratory. Following the large-scale investment phase, capital expenditures significantly decreased to ¥1,152 million from ¥3,118 million in the prior period.

Key Products

product
Organic Sulfur Compounds (Thio Products)

Mainly used for lens materials for plastic lens manufacturers and for cement additive manufacturers in China and Europe. In FY2026 (ending March 2026), both revenue and profit increased due to increased sales volume and price corrections. Maintains a top market share position in the high-refractive-index eyeglass lens material market.

service
Pharmaceutical APIs & Intermediates (CDMO)

A contract manufacturing business for pharmaceutical companies leveraging Katayama Seiyakusho Co., Ltd.'s new headquarters and research laboratory (in operation since September 2024). In FY2026 (ending March 2026), although the increase in contracted work for newly developed products did not proceed as expected, net sales increased due to an increase in production volume of existing contracted products. On the other hand, profit decreased due to the increased burden of depreciation expenses from the new headquarters and research laboratory.

Growth Drivers

  • Continued increase in sales volume and price corrections for Organic Sulfur Compounds (Thio Products) in lens and cement additive applications
  • Expansion of CDMO contracted projects and mass production of newly developed products, leveraging Katayama Seiyakusho Co., Ltd.'s new headquarters and research laboratory (in operation since September 2024)
  • Growth of the high-refractive-index eyeglass lens material market and strengthening of the top market share position
  • Positioning as a growth driver under the medium-term management plan 'Transformation, BEYOND2030' and continuous business expansion
  • Development of new applications for products under development, such as adhesives for electronic devices

Risks

  • Risk of demand fluctuation and customer inventory adjustments in the main applications of Organic Sulfur Products (lenses and cement additives)
  • Risk of decreased sales volume due to the economic slowdown in China and Europe
  • Risk of profit pressure from increased fixed costs (depreciation expenses) associated with the operation of Katayama Seiyakusho Co., Ltd.'s new headquarters and research laboratory (materialized in FY2026, ending March 2026)
  • Risk that the increase in contracted work for newly developed products in the CDMO business does not proceed as expected, and dependence on pharmaceutical companies' development pipeline trends
  • Risk of rising manufacturing costs due to higher raw material and fuel prices and yen depreciation

Hygiene Materials

A 'stable business' segment handling Super Absorbent Polymer, Breathable Film, and related products

PeriodCurrentPreviousChange
Net Sales (Full Year FY2026, ending March 2026)¥5,353 million¥5,623 million↓
Operating Profit (Full Year FY2026, ending March 2026)¥457 million¥427 million↑
Segment Assets (End of FY2026, ending March 2026)¥7,383 million¥7,175 million↑
Depreciation and Amortization (Full Year FY2026, ending March 2026)¥214 million¥215 million—
Capital Expenditures (Increase in Tangible and Intangible Assets, Full Year FY2026, ending March 2026)¥234 million¥64 million↑

Business Details

A stable business that manufactures and sells Super Absorbent Polymer, Breathable Film, and related products. The main application is disposable diapers and other hygiene products, composed of two pillars: domestically sold imported products (for adults and pets) and overseas manufacturing and sales (Indonesia). Positioned as a 'stable business' under the medium-term management plan 'Transformation, BEYOND2030,' with profitability improvements being pursued through increased domestic sales volume and cost reductions.

Recent Overview

Net sales decreased 4.8% year-on-year, but operating profit increased 7.1% due to cost reductions

In FY2026 (ending March 2026), net sales were ¥5,353 million (down 4.8% year-on-year), and operating profit was ¥457 million (up 7.1% year-on-year). In the domestic market, sales volumes of Breathable Film, nonwoven fabric, Super Absorbent Polymer, and other products increased. Meanwhile, in the film manufacturing business in Indonesia, sales volume was sluggish due to intensifying competition between the major customer and local companies, but as a result of cost reduction efforts, operating profit exceeded the prior period.

Key Products

product
Super Absorbent Polymer

A super absorbent resin used as a hygiene component in disposable diapers and sanitary products. Sales volume in the domestic market is increasing, maintaining stable demand.

product
Breathable Film

Breathable film and nonwoven fabric used as hygiene components in disposable diapers and similar products. While sales volume increased in the domestic market, the manufacturing and sales business in Indonesia has struggled with sluggish sales volume due to intensifying competition between the major customer and local companies.

Growth Drivers

  • Steady demand in the domestic market for hygiene materials for adults and pets
  • Increased sales volume of Breathable Film, nonwoven fabric, and Super Absorbent Polymer in the domestic market
  • Improved profitability through cost reductions in the Indonesian business
  • Expansion into untapped markets such as the Middle East, Europe, and Africa
  • Development and expansion of value-added products such as environmentally friendly Breathable Film

Risks

  • Sluggish sales volume due to intensifying competition between the major customer and local companies in the Indonesian disposable diaper market
  • Rising labor costs and expenses due to inflation in Indonesia
  • Intensifying competition due to price offensives from Chinese products
  • Shrinking market for children's products due to Japan's declining birthrate
  • Rising domestic sales costs and declining profit margins for imported products due to yen depreciation

Contract Processing

A 'stable business' segment responsible for contract processing of colored pavement and coating agents

PeriodCurrentPreviousChange
Net Sales (External Customers)¥6,677 million (full year FY2026, ending March 2026)¥6,422 million (full year FY2025, ended March 2025)↑
Operating Profit¥805 million (full year FY2026, ending March 2026)¥620 million (full year FY2025, ended March 2025)↑
Segment Assets¥8,235 million (end of FY2026, ending March 2026)¥8,834 million (end of FY2025, ended March 2025)↓
Depreciation and Amortization¥405 million (full year FY2026, ending March 2026)¥436 million (full year FY2025, ended March 2025)↓
Capital Expenditures (Increase in Tangible and Intangible Assets)¥195 million (full year FY2026, ending March 2026)¥148 million (full year FY2025, ended March 2025)↑

Business Details

Undertakes Contract Processing of processed pigments such as Processed Pigments (Colored Pavement & Coating Agents), and Process Outsourcing (Firing, Mixing, Drying, etc.) such as mixing, filtration/washing, drying, and firing. In addition to stable production and sales for major customers, the segment also focuses on acquiring new projects. Positioned as a 'stable business' under the medium-term management plan 'Transformation, BEYOND2030,' aiming to build a trusted contract processing framework through the expansion of owned equipment, sophistication of production management, and maintenance of high technical capabilities.

Recent Overview

Both net sales and operating profit increased, achieving a substantial improvement in profit compared to the prior period

In FY2026 (ending March 2026), net sales reached ¥6,677 million (up 4.0% year-on-year), and operating profit reached ¥805 million (up 29.8% year-on-year). For Processed Pigments, while demand for construction material applications continued to decline, other fields trended steadily, and new proposals and profitability corrections were successful. For Process Outsourcing as well, both revenue and profit increased due to stable sales to major customers and the acquisition of new projects and growth of ongoing projects.

Key Products

product
Processed Pigments (Colored Pavement & Coating Agents)

While demand for construction material applications has decreased due to the declining trend in domestic housing starts, other fields have generally trended steadily. Both revenue and profit increased through the promotion of new proposals and profitability corrections.

service
Process Outsourcing (Firing, Mixing, Drying, etc.)

In addition to stable sales to major customers, both revenue and profit increased through the acquisition of new projects and the growth of ongoing projects. The segment continues to strengthen its ability to respond to diversifying and increasingly sophisticated customer needs.

Growth Drivers

  • Recovery in contracted volume of existing products and acquisition of new projects in Process Outsourcing
  • Promotion of new proposals and profitability corrections in Processed Pigments
  • Strengthening of the contract processing framework through the expansion of owned equipment and sophistication of production management
  • Cultivation of new customers through enhanced web marketing

Risks

  • Decreased demand for processed pigments for construction material applications due to declining domestic housing starts
  • Risk of short-term demand fluctuations due to customer inventory adjustments
  • Risk of insufficient ability to respond to diversifying and increasingly sophisticated customer needs
  • Risk of rising manufacturing costs due to higher raw material and fuel prices

Titanium Oxide & Zinc Products (Efficiency Review Business)

An efficiency review segment shifting focus to zinc products following the completion of the pigment-grade titanium oxide business termination

PeriodCurrentPreviousChange
Net Sales (Full Year)¥10,244 million¥13,118 million↓
Operating Profit (Full Year)¥1,222 million¥1,479 million↓
Segment Assets¥12,925 million¥18,992 million↓
Depreciation and Amortization (Full Year)¥147 million¥179 million↓
Increase in Tangible and Intangible Assets (Full Year)-¥473 million-¥1,058 million—
Operating Profit Margin11.9%11.3%↑

Business Details

A segment that manufactures and sells Rutile Titanium Oxide, Zinc Oxide, and related products. Positioned as an 'efficiency review business' under the medium-term management plan 'Transformation, BEYOND2030.' As planned, the pigment-grade titanium oxide business was terminated in FY2026 (ending March 2026), resulting in a substantial decrease in both revenue and profit. Sales volume of zinc products also decreased, putting the segment overall in a phase of contraction. As a subsequent event, following the termination of the titanium oxide business, the industrial waste final disposal site (Iwaki City, Fukushima Prefecture) that became unnecessary was transferred to Daiei Kankyo Co., Ltd. in April 2026.

Recent Overview

Substantial contraction with net sales down 21.9% and operating profit down 17.4% due to termination of the titanium oxide business

In FY2026 (ending March 2026), production of pigment-grade titanium oxide was terminated as planned, and due to the resulting decrease in sales volume, net sales decreased 21.9% year-on-year to ¥10,244 million, and operating profit decreased 17.4% year-on-year to ¥1,222 million. Sales volume of zinc products also decreased, resulting in decreases in both revenue and profit. As a subsequent event, the industrial waste final disposal site that became unnecessary following the termination of the titanium oxide business was transferred to Daiei Kankyo Co., Ltd., with a gain on sale of fixed assets of ¥1,171 million expected to be recorded in FY2027 (ending March 2027).

Key Products

product
Rutile Titanium Oxide (Pigment Grade)

Against a backdrop of deteriorating market conditions due to the influx of inexpensive imported products, this product was positioned as part of the efficiency review business under the medium-term management plan, and production and sales were terminated as planned in FY2026 (ending March 2026). Accounts receivable and inventory decreased significantly following the business termination, and related fixed assets were also sold.

product
Zinc Oxide

The main product following the termination of the titanium oxide business. Sales volume decreased in the current period, resulting in decreases in both revenue and profit year-on-year. Efforts are being made to maintain profitability through price corrections and stable operations, but the product is susceptible to market conditions and demand fluctuations.

Growth Drivers

  • Improved asset efficiency through the sale and disposal of unprofitable assets following the termination of the titanium oxide business
  • Maintenance of profitability through the penetration of price corrections (price revisions) for zinc products
  • Reduction of fixed costs and improvement of utilization rate through equipment consolidation and labor savings
  • Improved profit margin through reduced depreciation burden on already-impaired assets

Risks

  • Structural and irreversible contraction of revenue due to the termination of the pigment-grade titanium oxide business
  • Risk of continued decline in sales volume of zinc products
  • Impact on revenue and profit of zinc products due to declining domestic zinc market conditions
  • Future decrease in sales volume due to the shift toward environmentally friendly specifications in the tire market
  • Risk of rising manufacturing costs due to higher raw material and fuel prices and yen depreciation

Resin Additives

An efficiency review business developing PVC Stabilizer both domestically and internationally

PeriodCurrentPreviousChange
Net Sales (Full Year)¥11,507 million¥13,061 million↓
Operating Profit (Full Year)¥1,068 million¥1,393 million↓
Segment Assets¥14,577 million¥16,778 million↓
Depreciation and Amortization (Full Year)¥301 million¥336 million↓
Increase in Tangible and Intangible Assets (Full Year)¥1 million¥308 million↓

Business Details

Mainly features Metal Soap, Tin-Based Stabilizer, and other stabilizers for PVC resin, manufactured and sold at three locations: Japan (Sakai Chemical and Kyodo Yakuhin), Vietnam (SAKAI CHEMICAL (VIETNAM) CO., LTD.), and Thailand (SIAM STABILIZERS AND CHEMICALS CO., LTD.). Positioned as an 'efficiency review business' under the medium-term management plan 'Transformation, BEYOND2030,' aiming for a transition to a stable business through the expansion of lead-free stabilizers in Southeast Asia. Domestically, the company is promoting the planned withdrawal from lead-based stabilizers and price revisions, while overseas, it is strengthening technical support for local staff.

Recent Overview

Both revenue and profit decreased due to the completion of the withdrawal from lead-based stabilizers and sluggish domestic demand

Net sales for FY2026 (ending March 2026) were ¥11,507 million (down 11.9% year-on-year), and operating profit was ¥1,068 million (down 23.3% year-on-year). Domestically, while the profit margin improved due to the effect of price revisions, both revenue and profit decreased due to continued sluggish demand for PVC resin and the planned withdrawal from lead-based stabilizers. Overseas, net sales increased due to expanded sales at the newly established northern Vietnam sales office, but profit decreased due to the impact of the economic slowdown caused by political instability in Thailand.

Key Products

product
PVC Stabilizer (Lead-Free)

A lead-free stabilizer promoting a transition from lead-based stabilizers. Domestically, the planned withdrawal from lead-based stabilizers has been completed, and the shift to lead-free products is progressing. Expansion of sales in the Southeast Asian market is positioned as a pillar of the growth strategy.

product
Metal Soap

Manufactures and sells calcium, zinc, and other metal soaps. A key constituent of PVC stabilizers, supplied to resin processing manufacturers domestically and internationally.

product
Tin-Based Stabilizer

A tin-based stabilizer mainly used for rigid PVC applications. Supplied to PVC processing manufacturers domestically and internationally, with profitability corrections being promoted through price revisions.

Growth Drivers

  • Increased sales volume through new expansion of lead-free stabilizers for Southeast Asia (sales expansion effect from the new northern Vietnam sales office)
  • Improved profit margin through the penetration of price revisions in response to rising raw material costs, both domestically and internationally
  • Strengthened technical support for local staff at the Vietnamese and Thai local subsidiaries
  • Improved profitability through the discontinuation of lead-based stabilizers and product consolidation in Japan
  • New adoption and expanded share in global markets leveraging formulation technology

Risks

  • Decreased sales volume of PVC stabilizers due to continued sluggish domestic PVC resin demand
  • Adverse impact on the performance of the local subsidiary due to economic slowdown caused by political instability in Thailand
  • Decreased sales to China due to the continued slump in the Chinese housing-related market
  • Deterioration of the domestic market environment due to the influx of inexpensive imported products
  • Risk of rising manufacturing costs due to soaring raw material (metal) prices

Catalysts (Efficiency Review Business)

An efficiency review business segment manufacturing and selling Denitration Catalyst and Nickel catalyst

PeriodCurrentPreviousChange
Net Sales (Segment Total, Full Year FY2026, ending March 2026)¥3,565 million¥3,226 million↑
Net Sales to External Customers (Full Year FY2026, ending March 2026)¥3,462 million¥3,186 million↑
Operating Profit (Full Year FY2026, ending March 2026)¥648 million¥18 million↑
Segment Assets (End of FY2026, ending March 2026)¥7,402 million¥5,490 million↑
Depreciation and Amortization (Full Year FY2026, ending March 2026)¥263 million¥269 million↓
Increase in Tangible and Intangible Assets (Full Year FY2026, ending March 2026)¥443 million¥1,521 million↓

Business Details

Mainly features Denitration Catalyst (for thermal power plants and waste incineration facilities) and Reduced Nickel Catalyst (for the hydrogenated petroleum resin manufacturing process). The Company handles manufacturing and sales, while Sakai Trading Co., Ltd., SAKAI TRADING NEW YORK INC., Sakai Trading (Shanghai) Co., Ltd., and SAKAI TRADING (THAILAND) CO., LTD. handle sales. Positioned as an 'efficiency review business' under the medium-term management plan 'Transformation, BEYOND2030,' with efficiency through the consolidation of production sites and securing profitability through improved sales mix toward high-quality products as key challenges.

Recent Overview

Operating profit sharply recovered to ¥648 million, up 3,338.7% year-on-year, driven by increased nickel catalyst volume and price corrections

Net sales to external customers for FY2026 (ending March 2026) were ¥3,462 million (up 8.6% year-on-year), and operating profit substantially improved to ¥648 million (up 3,338.7% year-on-year). Nickel catalyst saw both revenue and profit increase due to successful increases in shipment volume to major customers and price corrections. Meanwhile, denitration catalyst saw both revenue and profit decrease due to a decrease in large-scale projects for thermal power plants and a temporary cost increase associated with equipment renewal within the plant. Contributions from certain prototype products also contributed to the increase in net sales.

Key Products

product
Reduced Nickel Catalyst

Due to increased shipment volume to major customers and price corrections, both revenue and profit increased in FY2026 (ending March 2026). Nickel catalyst was the main product driving the profitability improvement in this segment.

product
Denitration Catalyst

In FY2026 (ending March 2026), sales volume decreased due to few large-scale projects for thermal power plants, and combined with a temporary cost increase associated with equipment renewal within the plant, both revenue and profit decreased.

Growth Drivers

  • Continued profitability improvement through increased shipment volume to major customers and price corrections for nickel catalyst
  • Emergence of fixed cost reduction and improved utilization rate effects through the consolidation of production sites
  • Expanded demand for denitration catalyst due to stricter exhaust gas regulations in East Asia and other overseas markets
  • Development and expansion of new catalysts through collaboration with carbon-neutral related companies
  • Improved profitability through a shift in sales mix toward high-quality products

Risks

  • Declining trend in large-scale projects for thermal power plants for denitration catalyst and instability in sales volume
  • Risk of temporary cost increases during production suspension periods associated with equipment renewal within the plant
  • Performance fluctuations for nickel catalyst due to the timing of major customers' periodic maintenance and equipment renewal
  • Uncertainty in overseas demand due to the economic slowdown in China and reciprocal tariffs
  • Risk of nickel catalyst demand being linked to demand trends in the hydrogenated petroleum resin market

Inorganic Materials (Efficiency Review Business)

An efficiency review business segment manufacturing and selling Precipitated Barium Sulfate, Strontium Carbonate, and related products

PeriodCurrentPreviousChange
Net Sales (Full Year)¥5,100 million¥5,175 million↓
Operating Profit (Full Year)¥1,200 million¥826 million↑
Segment Assets¥8,409 million¥7,601 million↑
Depreciation and Amortization (Full Year)¥94 million¥95 million—
Capital Expenditures (Increase in Tangible and Intangible Assets)¥832 million¥440 million↑
Impairment Loss¥0 million¥164 million↓

Business Details

A segment that manufactures and sells Precipitated Barium Sulfate, Strontium Carbonate, Zirconium Oxide Dispersion (SZR), and related products. The main application is for paints and inks, holding a position as the only domestic manufacturer of chemically synthesized Precipitated Barium Sulfate. Sakai Trading Co., Ltd., SAKAI TRADING NEW YORK INC., Sakai Trading (Shanghai) Co., Ltd., and Sakai Trading Taiwan Co., Ltd. handle sales. Positioned as an 'efficiency review business' under the medium-term management plan 'Transformation, BEYOND2030,' promoting profitability improvement through cost reduction, improved production efficiency, and expanded sales of high-value-added products.

Recent Overview

Net sales slightly decreased, but operating profit increased 45.2% year-on-year due to cost reductions and contributions from high-value-added products

Net sales for FY2026 (ending March 2026) were ¥5,100 million (down 1.4% year-on-year), a slight decrease, while operating profit substantially improved to ¥1,200 million (up 45.2% year-on-year). In addition to cost reduction and improved production efficiency, stable shipment of the high-value-added Zirconium Oxide Dispersion SZR contributed to the increase in profit. The impairment loss of ¥164 million recorded in the prior period was zero in the current period, resolving the burden on the extraordinary loss side as well.

Key Products

product
Precipitated Barium Sulfate

Manufactured and sold as the only domestic manufacturer of chemically synthesized Precipitated Barium Sulfate. The paints and inks market is the main focus, with price corrections and profitability improvements being promoted amid competitive conditions with Chinese products.

product
Strontium Carbonate

Manufactured and sold for applications such as electronic components and magnetic materials. Positioned as one of the main products within the segment.

product
Zirconium Oxide Dispersion (SZR)

Zirconium Oxide Dispersion SZR, positioned as a high-value-added product. In FY2026 (ending March 2026), stable shipment continued to contribute to increased profit, driving the improvement in the segment's profitability.

Growth Drivers

  • Continued profitability improvement through cost reduction and improved production efficiency
  • Stable shipment and expanded sales of the high-value-added product (Zirconium Oxide Dispersion SZR)
  • Improved profit margin through the penetration of price corrections (profitability corrections)
  • Improvement in profit and loss structure through the resolution of the impairment loss (¥164 million) recorded in the prior period
  • Improved profit structure through product consolidation and manufacturing efficiency improvements

Risks

  • Deterioration of the domestic market environment due to price offensives from Chinese products (barium sulfate)
  • Risk of decreased sales volume due to sluggish demand in the paints and inks market
  • Rising manufacturing costs due to higher raw material and fuel prices and yen depreciation
  • Decreased export-oriented demand due to the economic slowdown in China
  • Risk of medium- to long-term business contraction and reorganization, given its position as an efficiency review business

Medical Business

A comprehensive medical business manufacturing and selling prescription and OTC drugs and medical devices

PeriodCurrentPreviousChange
Net Sales (Full Year FY2026, ending March 2026)¥8,391 million¥8,321 million↑
Operating Profit (Loss) (Full Year FY2026, ending March 2026)-¥48 million-¥24 million↓
Segment Assets (End of FY2026, ending March 2026)¥10,553 million¥10,757 million↓
Impairment Loss (Full Year FY2026, ending March 2026)¥14 million¥106 million↓

Business Details

The Medical Business manufactures and sells prescription pharmaceuticals such as Barium Contrast Agent and the peptic ulcer treatment 'Alloid G Internal Solution 5%,' OTC drugs such as the cold medicine 'Kaigen,' and medical devices such as the Endoscope Washer-Disinfector 'KD-1' and the bone filling material 'REVOSIS.' The three priority areas are health checkups, gastroenterology, and beauty, with the cultivation of new businesses unaffected by drug price revisions also being promoted. In FY2026 (ending March 2026), although net sales increased slightly, the operating loss continued due to drug price reductions for prescription pharmaceuticals and the rebound from special demand for OTC drugs, among other factors.

Recent Overview

Net sales increased slightly but the operating loss widened, with a mix of decreased pharmaceutical sales and increased device sales

In FY2026 (ending March 2026), the Medical Business posted net sales of ¥8,391 million (up 0.8% year-on-year), a slight increase, but the operating loss widened to ¥48 million (from a loss of ¥24 million in the prior period). Prescription pharmaceuticals struggled, with both Barium Contrast Agent and Alloid G facing drug price reductions and decreased sales volume. OTC drugs also declined due to the rebound from the prior year's special demand. Meanwhile, the Endoscope Washer-Disinfector 'KD-1' achieved increased revenue and profit due to replacement demand and price increases for consumables, and the bone filling material 'REVOSIS' also contributed due to increased contracted production. The impairment loss significantly decreased from ¥106 million in the prior period to ¥14 million.

Key Products

product
Barium Contrast Agent

In FY2026 (ending March 2026), sales volumes decreased both domestically and internationally, resulting in decreases in both revenue and profit.

product
Peptic Ulcer Treatment "Alloid G Internal Solution 5%"

In FY2026 (ending March 2026), both revenue and profit decreased due to the impact of drug price reductions and decreased sales volume, in addition to the impact of rising raw material costs.

product
Endoscope Washer-Disinfector "KD-1"

In FY2026 (ending March 2026), sales volume increased, partly due to the promotion of replacement from older models. Price increases for consumables and test meals also contributed, resulting in increases in both revenue and profit.

product
Bone Filling Material "REVOSIS"

In FY2026 (ending March 2026), both revenue and profit increased due to an increase in contracted production volume.

product
OTC Drugs (Cold Medicine "Kaigen", etc.)

In FY2026 (ending March 2026), sales volume declined due to the rebound from the prior year's OTC special demand caused by the shortage of supply of prescription antitussive and expectorant drugs, and due to a less prevalent cold season compared to the prior year, resulting in decreases in both revenue and profit.

product
Beauty Products (Supplements, etc.)

In FY2026 (ending March 2026), sales decreased due to the impact of discontinuing the handling of purchased and resold products from other companies, but profit exceeded the prior year due to the advanced launch of a renewed product as a recovery measure in response to a voluntary recall of supplements attributable to a raw material manufacturer.

Growth Drivers

  • Replacement demand for the Endoscope Washer-Disinfector 'KD-1' from older models and the effect of price increases for consumables and test meals
  • Increase in contracted production volume for the bone filling material 'REVOSIS'
  • Recovery in profitability through the advanced launch of a renewed beauty product
  • Expansion of the product lineup in the three priority areas of health checkups, gastroenterology, and beauty
  • Expansion of the medical device and consumables areas unaffected by drug price revisions

Risks

  • Pressure on profitability of prescription pharmaceuticals (Barium Contrast Agent, Alloid G, etc.) due to the drug price reduction trend
  • Rising manufacturing costs due to higher raw material and fuel prices
  • Demand fluctuation risk for OTC drugs (rebound from special demand, seasonal fluctuations in prevalent illnesses, etc.)
  • Instability of beauty product sales due to discontinuation of handling of purchased and resold products from other companies, etc.
  • Risk of impairment of fixed assets (an impairment loss of ¥14 million was recorded in the full year of FY2026, ending March 2026)
  • Increased quality control costs associated with maintaining the GQP/GMP framework

Others

A diversified, small-scale segment handling Phosphate Compounds, nickel acetate, road marking materials, and more

PeriodCurrentPreviousChange
Net Sales (External Customers, Full Year)¥10,427 million¥10,169 million↑
Segment Profit (Full Year)¥1,498 million¥1,171 million↑
Segment Assets (End of Period)¥12,269 million¥12,468 million↓
Depreciation and Amortization (Full Year)¥226 million¥220 million↑
Increase in Tangible and Intangible Assets (Full Year)¥270 million¥216 million↑

Business Details

The 'Others' segment sells Phosphate Compounds and manufactures and sells nickel acetate, road marking materials, and related products. The main subsidiaries are Osaki Industry Co., Ltd. (manufacturing and sales) and several domestic and overseas sales subsidiaries including Sakai Trading Co., Ltd., SAKAI AUSTRALIA PTY LTD., and SAKAI TRADING NEW YORK INC. The product lineup is diverse, supplied to a wide range of domestic and overseas customers. Net sales to external customers for FY2026 (ending March 2026) were ¥10,427 million, continuing to trend steadily with a 2.5% increase year-on-year on a consolidated basis.

Recent Overview

Both net sales and profit increased year-on-year, resulting in improved profitability

Net sales to external customers for FY2026 (ending March 2026) were ¥10,427 million (up 2.5% year-on-year), and segment profit was ¥1,498 million (up 27.9% year-on-year), achieving increased revenue and profit. Segment assets decreased by ¥199 million from the end of the prior period to ¥12,269 million, while the increase in tangible and intangible assets rose by ¥54 million year-on-year to ¥270 million, indicating that selective capital investment is continuing.

Key Products

product
Phosphate Compounds

Sold to domestic and overseas customers, mainly for industrial applications. One of the main product groups within the segment.

product
Nickel Acetate

Manufactured and sold mainly by Osaki Industry Co., Ltd. Supplied domestically and internationally for industrial applications.

product
Road Marking Materials

Manufactures and sells road marking materials for road infrastructure. Mainly supplied to the domestic construction and civil engineering market.

Growth Drivers

  • Improvement in sales volume and pricing that achieved a 2.5% increase in revenue compared to the prior consolidated fiscal year
  • Expansion of manufacturing and sales centered on Osaki Industry Co., Ltd.
  • Utilization of the global sales network through overseas subsidiaries such as SAKAI AUSTRALIA PTY LTD.
  • Strengthening of intra-group sales collaboration through Sakai Trading Co., Ltd.

Risks

  • Susceptibility to market fluctuations and demand decreases for individual products, given the diverse product lineup
  • Risk of deteriorating export environment due to the economic slowdown in China and reciprocal tariffs
  • Risk of rising manufacturing costs due to higher raw material and fuel prices and yen depreciation
  • Possibility of business scale contraction, given the declining trend in segment assets compared to the end of the prior period

Last updated: July 17, 2026